{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T11:39:06Z","timestamp":1791545946764,"version":"4.3.4"},"reference-count":41,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T00:00:00Z","timestamp":1717372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxins"],"abstract":"<jats:p>The goal-setting process is pivotal in managing patients with disabling spasticity. This case\u2013control study assessed the role of diagnostic nerve blocks in guiding the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A. In this case\u2013control study, patients with disabling spasticity underwent either a goal-setting process based on the patient\u2019s needs and clinical evaluation (control group) or additional diagnostic nerve block procedures (case group). All enrolled patients underwent a focal treatment with botulinum neurotoxin-A injection and a 1-month follow-up evaluation during which goal achievement was quantified using the goal attainment scaling-light score system. Data showed a higher goal achievement rate in the case group (70%) than in the control group (40%). In conclusion, diagnostic nerve blocks may help guide the goal-setting process within goal-targeted treatment of spasticity with botulinum neurotoxin-A towards more realistic and achievable goals, thereby improving the outcomes of botulinum neurotoxin-A injection. Future studies should better explore the role of diagnostic nerve blocks to further personalize botulinum neurotoxin-A according to individual patients\u2019 preferences and requirements.<\/jats:p>","DOI":"10.3390\/toxins16060258","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T05:58:00Z","timestamp":1717394280000},"page":"258","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Role of Diagnostic Nerve Blocks in the Goal-Oriented Treatment of Spasticity with Botulinum Toxin Type A: A Case\u2013Control Study"],"prefix":"10.3390","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5930-5974","authenticated-orcid":false,"given":"Mirko","family":"Filippetti","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1561-2187","authenticated-orcid":false,"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Di Censo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Adamo","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Manera","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Ingr\u00e0","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3717-7697","authenticated-orcid":false,"given":"Elisa","family":"Mantovani","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6748-9152","authenticated-orcid":false,"given":"Salvatore","family":"Facciorusso","sequence":"additional","affiliation":[{"name":"Spasticity and Movement Disorders \u2018ReSTaRt\u2019 Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti Hospital, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1357-1374","authenticated-orcid":false,"given":"Marco","family":"Battaglia","sequence":"additional","affiliation":[{"name":"Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8440-6283","authenticated-orcid":false,"given":"Alessio","family":"Baricich","sequence":"additional","affiliation":[{"name":"Physical and Rehabilitative Medicine, Department of Health Sciences, University of Eastern Piedmont \u201cA. Avogadro\u201d, 28100 Novara, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1452-8485","authenticated-orcid":false,"given":"Andrea","family":"Santamato","sequence":"additional","affiliation":[{"name":"Spasticity and Movement Disorders \u2018ReSTaRt\u2019 Unit, Physical Medicine and Rehabilitation Section, Policlinico Riuniti Hospital, University of Foggia, 71122 Foggia, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7630-1887","authenticated-orcid":false,"given":"Nicola","family":"Smania","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3558-8276","authenticated-orcid":false,"given":"Alessandro","family":"Picelli","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, 37100 Verona, Italy"},{"name":"Canadian Advances in Neuro-Orthopedics for Spasticity Consortium (CANOSC), Kingston, ON K7K 1Z6, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,6,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1191\/0269215502cr512oa","article-title":"Prevalence of spasticity post stroke","volume":"5","author":"Watkins","year":"2002","journal-title":"Clin. Rehabil."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s40271-016-0173-0","article-title":"A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis","volume":"6","author":"Bethoux","year":"2016","journal-title":"Patient"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1191\/1352458504ms1085oa","article-title":"Prevalence and treatment of spasticity reported by multiple sclerosis patients","volume":"5","author":"Rizzo","year":"2004","journal-title":"Mult. Scler."},{"key":"ref_4","first-page":"1386","article-title":"Pharmacological management of spasticity in multiple sclerosis: Systematic review and consensus paper","volume":"11","author":"Comi","year":"2016","journal-title":"Mult. Scler."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s00415-016-8304-z","article-title":"Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: Review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force","volume":"1","author":"Dressler","year":"2017","journal-title":"J. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology","volume":"19","author":"Simpson","year":"2016","journal-title":"Neurology"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Asimakidou, E., and Sidiropoulos, C. (2023). A Bayesian Network Meta-Analysis and Systematic Review of Guidance Techniques in Botulinum Toxin Injections and Their Hierarchy in the Treatment of Limb Spasticity. Toxins, 4.","DOI":"10.3390\/toxins15040256"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.rehab.2019.06.001","article-title":"French clinical guidelines for peripheral motor nerve blocks in a PRM setting","volume":"4","author":"Yelnik","year":"2019","journal-title":"Ann. Phys. Rehabil. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.apmr.2023.01.011","article-title":"Recommendations for Ultrasound Guidance for Diagnostic Nerve Blocks for Spasticity. What Are the Benefits?","volume":"9","author":"Winston","year":"2023","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2340\/16501977-2226","article-title":"Assessment and treatment of spastic equinovarus foot after stroke: Guidance from the Mont-Godinne interdisciplinary group","volume":"49","author":"Deltombe","year":"2017","journal-title":"J. Rehabil. Med."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.apmr.2022.07.020","article-title":"International Recommendations to Manage Poststroke Equinovarus Foot Deformity Validated by a Panel of Experts Using Delphi","volume":"3","author":"Salga","year":"2023","journal-title":"Arch. Phys. Med. Rehabil."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1161\/STROKEAHA.111.639831","article-title":"Poststroke spasticity management","volume":"11","author":"Francisco","year":"2012","journal-title":"Stroke"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"104376","DOI":"10.1016\/j.msard.2022.104376","article-title":"Symptom burden, management and treatment goals of people with MS spasticity: Results from SEEN-MSS, a large-scale, self-reported survey","volume":"68","author":"Newsome","year":"2022","journal-title":"Mult. Scler. Relat. Disord."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3138\/ptc.2016-25","article-title":"Goals Set by Patients Using the ICF Model before Receiving Botulinum Injections and Their Relation to Spasticity Distribution","volume":"2","author":"Choi","year":"2017","journal-title":"Physiother. Can."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e000015","DOI":"10.1136\/bmjno-2019-000015","article-title":"Real-life outcomes in spasticity management: Features affecting goal achievement","volume":"1","author":"Singh","year":"2020","journal-title":"BMJ Neurol. Open"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"jrm00069","DOI":"10.2340\/16501977-2693","article-title":"Diagnostic nerve block in prediction of outcome of botulinum toxin treatment for spastic equinovarus foot after stroke: A retrospective observational study","volume":"6","author":"Picelli","year":"2020","journal-title":"J. Rehabil. Med."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Scaglione, F. (2016). Conversion Ratio between Botox\u00ae, Dysport\u00ae, and Xeomin\u00ae in Clinical Practice. Toxins, 8.","DOI":"10.3390\/toxins8030065"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Jacinto, J., Balbert, A., Bensmail, D., Carda, S., Draulans, N., Deltombe, T., Ketchum, N., Molteni, F., and Reebye, R. (2023). Selecting Goals and Target Muscles for Botulinum Toxin A Injection Using the Goal Oriented Facilitated Approach to Spasticity Treatment (GO-FAST) Tool. Toxins, 12.","DOI":"10.3390\/toxins15120676"},{"key":"ref_19","first-page":"jrm00133","article-title":"Assessing the effectiveness of upper-limb spasticity management using a structured approach to goal-setting and outcome measurement: First cycle results from the ULIS-III Study","volume":"1","author":"Jacinto","year":"2021","journal-title":"J. Rehabil. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1080\/09638288.2018.1451927","article-title":"Categorisation of goals set using Goal Attainment Scaling for treatment of leg spasticity: A multicentre analysis","volume":"16","author":"Ashford","year":"2019","journal-title":"Disabil. Rehabil."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Baccouche, I., Bensmail, D., Leblong, E., Fraudet, B., Aymard, C., Quintaine, V., Pottier, S., Lansaman, T., Malot, C., and Gallien, P. (2022). Goal-Setting in Multiple Sclerosis-Related Spasticity Treated with Botulinum Toxin: The GASEPTOX Study. Toxins, 9.","DOI":"10.3390\/toxins14090582"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/WCO.0000000000001114","article-title":"Spasticity following brain and spinal cord injury: Assessment and treatment","volume":"6","author":"Tamburin","year":"2022","journal-title":"Curr. Opin. Neurol."},{"key":"ref_23","first-page":"jrm00241","article-title":"European expert consensus on improving patient selection for the management of disabling spasticity with intrathecal baclofen and\/or botulinum toxin type A","volume":"54","author":"Stevenson","year":"2022","journal-title":"J. Rehabil. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/ejhpharm-2019-002040","article-title":"Goal attainment scaling to facilitate person-centred, medicines-related consultations","volume":"2","author":"Clarkson","year":"2021","journal-title":"Eur. J. Hosp. Pharm."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ejpain.2003.09.004","article-title":"Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale","volume":"4","author":"Salaffi","year":"2004","journal-title":"Eur. J. Pain"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.gaitpost.2010.10.094","article-title":"Excellent test-retest and inter-rater reliability for Tardieu Scale measurements with inertial sensors in elbow flexors of stroke patients","volume":"2","author":"Paulis","year":"2011","journal-title":"Gait Posture"},{"key":"ref_27","first-page":"111","article-title":"BoTULS: A multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A","volume":"26","author":"Shaw","year":"2010","journal-title":"Health Technol. Assess."},{"key":"ref_28","first-page":"279","article-title":"Reliability of three measures of ankle dorsiflexion range of motion","volume":"7","author":"Konor","year":"2012","journal-title":"Int. J. Sports Phys. Ther."},{"key":"ref_29","first-page":"75","article-title":"Reliability of gait performance tests in men and women with hemiparesis after stroke","volume":"2","author":"Flansbjer","year":"2005","journal-title":"J. Rehabil. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1545968308331146","article-title":"Test-retest reproducibility and smallest real difference of 5 hand function tests in patients with stroke","volume":"5","author":"Chen","year":"2009","journal-title":"Neurorehabil. Neural Repair"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1081\/COPD-200050527","article-title":"Minimal clinically important differences in the six-minute walk test and the incremental shuttle walking test","volume":"1","author":"Wise","year":"2005","journal-title":"COPD J. Chronic Obstr. Pulm. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2522\/ptj.20090079","article-title":"Meaningful gait speed improvement during the first 60 days poststroke: Minimal clinically important difference","volume":"2","author":"Tilson","year":"2010","journal-title":"Phys. Ther."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"jrm00275","DOI":"10.2340\/jrm.v54.85","article-title":"Is the Outcome of Diagnostic Nerve Block Related to Spastic Muscle Echo Intensity? A Retrospective Observational Study on Patients with Spastic Equinovarus Foot","volume":"54","author":"Filippetti","year":"2022","journal-title":"J. Rehabil. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ajum.12354","article-title":"Anatomical landmarks for ultrasound-guided rectus femoris diagnostic nerve block in post-stroke spasticity","volume":"4","author":"Facciorusso","year":"2023","journal-title":"Australas. J. Ultrasound Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1097\/PHM.0000000000000344","article-title":"Sonographic tracking of the upper limb peripheral nerves: A pictorial essay and video demonstration","volume":"94","author":"Wu","year":"2015","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/PHM.0000000000000463","article-title":"Sonographic Tracking of the Lower Limb Peripheral Nerves: A Pictorial Essay and Video Demonstration","volume":"95","author":"Hung","year":"2016","journal-title":"Am. J. Phys. Med. Rehabil."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pmrj.2016.06.016","article-title":"OnabotulinumtoxinA Injection for Poststroke Upper-Limb Spasticity: Guidance for Early Injectors from a Delphi Panel Process","volume":"9","author":"Simpson","year":"2017","journal-title":"Pm R"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/MRR.0b013e328353e3d4","article-title":"Classification of posture in poststroke upper limb spasticity: A potential decision tool for botulinum toxin A treatment?","volume":"35","author":"Hefter","year":"2012","journal-title":"Int. J. Rehabil. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.pmrj.2017.02.014","article-title":"OnabotulinumtoxinA for Lower Limb Spasticity: Guidance from a Delphi Panel Approach","volume":"9","author":"Esquenazi","year":"2017","journal-title":"PM R"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"469","DOI":"10.23736\/S1973-9087.17.04664-0","article-title":"Sonographic guide for botulinum toxin injections of the upper limb: EUROMUSCULUS\/USPRM spasticity approach","volume":"54","author":"Kara","year":"2018","journal-title":"Eur. J. Phys. Rehabil. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"486","DOI":"10.23736\/S1973-9087.17.04667-6","article-title":"Sonographic guide for botulinum toxin injections of the lower limb: EUROMUSCULUS\/USPRM spasticity approach","volume":"54","author":"Kaymak","year":"2018","journal-title":"Eur. J. Phys. Rehabil. Med."}],"container-title":["Toxins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6651\/16\/6\/258\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:52:48Z","timestamp":1760107968000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6651\/16\/6\/258"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,3]]},"references-count":41,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2024,6]]}},"alternative-id":["toxins16060258"],"URL":"https:\/\/doi.org\/10.3390\/toxins16060258","relation":{},"ISSN":["2072-6651"],"issn-type":[{"value":"2072-6651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,3]]}}}